Phibro Animal Health Corporation (PAHC) Plunges 9.06% on February 07

Equities Staff  |

Phibro Animal Health Corporation (PAHC) had a rough trading day for Thursday February 07 as shares tumbled 9.06%, or a loss of $-3.05 per share, to close at $30.60. After opening the day at $30.80, shares of Phibro Animal Health Corporation traded as high as $33.70 and as low as $30.00. Volume was 189,946 shares over 2,228 trades, against an average daily volume of n/a shares and a total float of 40.38 million.

As a result of the decline, Phibro Animal Health Corporation now has a market cap of $1.24 billion.

The stock has a P/E Ratio of 19.6.

In the last year, shares of Phibro Animal Health Corporation have traded between a range of $54.62 and $30.79, and its 50-day SMA is currently $n/a and 200-day SMA is $n/a.

For a complete fundamental analysis of Phibro Animal Health Corporation, check out Equities.com’s Stock Valuation Analysis report for PAHC.

Still paying commissions on stock trades? Equities.com now offers 100% commission free stock trading and flat-fee options trading for $89.95/month! Get started today by https://www.equities.com/trading

Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the US and other international countries.

Phibro Animal Health Corporation is based out of Teaneck, NJ and has some 1,500 employees. Its CEO is Jack Clifford Bendheim.

Phibro Animal Health Corporation is a component of the Russell 2000. The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

To get more information on Phibro Animal Health Corporation and to follow the company’s latest updates, you can visit the company’s profile page here: PAHC’s Profile. For more news on the financial markets and emerging growth companies, be sure to visit Equities.com’s Newsdesk. Also, don’t forget to sign-up for our daily email newsletter to ensure you don’t miss out on any of our best stories.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.



DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Watchlist

Symbol Last Price Change % Change
AAPL

     
AMZN

     
HD

     
JPM

     
IBM

     

INTERVIEW: CEO Steve Stanulis - Stanulis Films

Equities.com's Sam Mitchell interviewing CEO Steve Stanulis of Stanulis Films.